New drug duo may shorten recovery time for blood cancer patients after transplant
NCT ID NCT07362810
First seen Jan 26, 2026 · Last updated Jun 10, 2026 · Updated 20 times
Summary
This study tests whether adding a drug called IL-11 to the standard G-CSF can help blood cancer patients recover their blood cells faster after a stem cell transplant. About 224 adults with multiple myeloma or lymphoma will take part. The goal is to see if the combination reduces the need for transfusions and shortens hospital stays.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMATOLOGIC MALIGNANCIES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Huadong Hospital, Fudan University
RECRUITINGShanghai, Shanghai Municipality, 200040, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The first affiliated hospital of Zhengzhou university
RECRUITINGZhengzhou, Henan, 450052, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Tongji Hospital of Tongji University
RECRUITINGShanghai, Shanghai Municipality, 200065, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.
Conditions inferred from the trial description
These were inferred from the trial's summary, not listed by the trial registrant.